Stemtech Corp. engages in the development of nutritional supplements. It offers RCM System, stemrelease3, StemFlo, MigraStem, OraStem, and Cellect One. It operates through the following geographical segments: North America, Latin America, and Asia. The North America segment refers to its subsidiaries in the United States and Canada. The Latin America segment includes subsidiaries in Mexico and Ecuador. The Asia segment relates to its subsidiaries in Malaysia and Taiwan. The company was founded in 2005 and is headquartered in Naples, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Stemtech Corp market cap is $2,997.00.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Stemtech Corp 52 week high is $0.0024 as of November 21, 2026.
Stemtech Corp stock price yesterday was $0.0001.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Stemtech Corp P/B ratio is -0.0004.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Stemtech Corp 50-day moving average is $0.0001.